HeartBeam, Inc. has appointed Timothy Cruickshank as Chief Financial Officer effective September 9, 2024. As part of the appointment, an employment agreement was signed providing Mr. Cruickshank with an annual salary of $385,000, potential incentive bonuses, and eligibility for certain benefits. Additionally, Mr. Cruickshank may be granted an option to purchase 400,000 shares of HeartBeam's Common Stock. Previously, Mr. Cruickshank served as a financial executive and CFO at ImpediMed since 2008. There are no disclosed family relationships or related party transactions associated with him. HeartBeam issued a press release on September 10, 2024, to announce the appointment.